Multifaceted participation of the ZMI at the Heidelberg Spring Symposium on Medical Informatics

Prof. Dr. Martin Sedlmayr part of the Scientific Committee – Dr. Eveline Prochaska and Dr. Markus Wolfien present the latest research topics

The 3rd "Heidelberg Spring Symposium Medical Informatics" took place on 28 May under the slogan "Medical Information Systems for Innovative Research and Care". The event focussed on 2 topics in particular: AI-supported medical information systems with Large Language Models (LLMs) and Patient Reported Outcome Measures (PROMs).

Our Director Prof. Dr. Martin Sedlmayr is a member of the Scientific Committee of the scientific event. The ZMI also sent Dr. Eveline Prochaska, one of the heads of the Interoperability research area, and Dr. Markus Wolfien, one of the heads of the Data Science research area, to the Neckarstadt. 

Dr. Eveline Prochaska gave a presentation on the topic of "ICFx - application for recording partcipation disorders on an ICF basis" and presented her research work on the web app "ICFx":

ICFx focuses on supporting people with physical and cognitive impairments and aims to help these patients make better use of their abilities in digital environments and reduce the barriers they experience when using websites and apps. It describes their level of participation on an ICF basis [ICF - International Classification of Functioning, Disability and Health] and is currently being validated in a clinical study.

Dr. Markus Wolfien contributed the article "Enhancing Molecular Tumour Boards with User-Centered Visualisations - Embedding PROMs in cBioPortal", which deals with the enrichment of molecular tumour boards with user-centred visualisations and the integration of PROMs into a web-based platform, the "cBioPortal".

This research stems from PM4Onco, a project of the Medical Informatics Initiative (MII), which aims to create an infrastructure to integrate data from clinical and biomedical research and thus promote personalised medicine in cancer treatment. PROMs that are integrated into Molecular Tumour Boards (MTBs) are a central component of this.

➡️ The abstracts for both contributions can be found here.

➡️ The relevant LinkedIn contribution is published here.

© Eveline Prochaska